TY  - CHAP
M1  - Book, Section
TI  - Rheumatologic, Immunologic, & Allergic Disorders Year in Review
A1  - Papadakis, Maxine A.
A1  - McPhee, Stephen J.
A1  - Rabow, Michael W.
A1  - McQuaid, Kenneth R.
PY  - 2023
T2  - Current Medical Diagnosis & Treatment 2023
AB  - Because  rituximab  reduces  the  humoral  immune  response,  it  should  be  used  with  caution  during  the  COVID-19  pandemic  as  multiple  studies  suggest  a  higher  risk  of  mortality  from  COVID-19  in  patients  using  this  medication.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/20
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1193123768
ER  -